Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ensifentrine by Verona Pharma for Allergic Asthma: Likelihood of Approval
Ensifentrine is under clinical development by Verona Pharma and currently in Phase II for Allergic Asthma. According to GlobalData, Phase...
Ensifentrine by Verona Pharma for Chronic Asthma: Likelihood of Approval
Ensifentrine is under clinical development by Verona Pharma and currently in Phase II for Chronic Asthma. According to GlobalData, Phase...
Ensifentrine by Verona Pharma for Cystic Fibrosis: Likelihood of Approval
Ensifentrine is under clinical development by Verona Pharma and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase...